ERBA Diagnostics, Inc. (NYSE MKT:ERB) will report its third quarter 2014 financial results Monday, November 10, 2014 at approximately 7:30 a.m.......Thanks got it;)
Top 14 things that will at some point soon become news/earnings and drive the stock price much higher:
1. Ebola connection - all over the news, ELISSA test news from CDC and ERB existing device. Plus increased business from flu season and Ebola fears. 2. The Medica Show - ERB partner companies' websites. 3. The award they received recently - Transasia website. 4. 6 new products showing at Medica - ERB partner companies' websites. 5. Real Estate sale - The ERB real estate will get sold. It is a hidden asset. Mohan spoke about it in the Q and A on the last conf call. He said we would hear something for sure before the end of the year. 6. Brazil - ERB conf call 7. Mexico - Already announced. Color on progress there. 8. Acquisitions - Announced on each and every press releases that they are looking to do more. 9. New approvals - Ongoing and announced earlier awaiting FDA approval by the end of the year. 10. Integration and partnering with ERB portfolio of companies - Logic and announced in their PR and IR efforts. 11. More investor conferences - Already started with JP Morgan show in SF. 12. Investor meetings and conf calls - As already demonstrated. 13. Earnings - Sales and Earnings up along with conf call for color - As demonstrated last quarter earnings up 400%. 14. Further consolidation and cost savings results realized - Efforts announced previously. http://finance.yahoo.com/mbview/threadview/;_ylt=ArjbKhpDpLsXBPc3gHwj5CveAohG;_ylu=X3oDMTB2bmJidWVyBHBvcwM0MgRzZWMDTWVkaWFNc2dCb2FyZHNYSFJVbHQ-;_ylg=X3oDMTBhYWM1a2sxBGxhbmcDZW4tVVM-;_ylv=3?&bn=d7f9061e-dc10-30a4-91eb-ccbb319b47ec&tid=1413568350042-ab1103b1-37c3-492e-9481-10d28235400e
Market Data 
Markets 
AI
